Novel pharmacological chaperones that correct phenylketonuria in mice-Reference-Cited by-同舟云学术

Novel pharmacological chaperones that correct phenylketonuria in mice

Published:2012-01-13 Issue:8 Volume:21 Page:1877-1887
ISSN:1460-2083
Container-title:Human Molecular Genetics
language:en
Short-container-title:

Author:

Santos-Sierra Sandra,Kirchmair Johannes,Perna Anna M.,Reiß Dunja,Kemter Kristina,Röschinger Wulf,Glossmann Hartmut,Gersting Søren W.,Muntau Ania C.,Wolber Gerhard,Lagler Florian B.

Publisher

Oxford University Press (OUP)

Subject

Genetics (clinical),Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/hmg/article-pdf/21/8/1877/17259404/dds001.pdf

Reference70 articles.

1. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency;Donlon,2007

2. Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence;Enns;Mol. Genet. Metab.,2010

3. Behaviour in early treated phenylketonuria: a systematic review;Smith;Eur. J. Pediatr.,2000

4. National Institutes of Health Consensus Development Conference Statement. Phenylketonuria: screening and management October 16–18, 2000;Panel;Pediatrics,2001

5. Dietary problems of phenylketonuria: effect on CNS transmitters and their possible role in behaviour and neuropsychological function;Guttler;J. Inherit. Metab. Dis.,1986

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of potential pharmacological chaperones that selectively stabilize mutated Aspartoacylases in Canavan disease;Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics;2024-11

2. PAH deficient pathology in humanized c.1066-11G>A phenylketonuria mice;Human Molecular Genetics;2024-03-23

3. PAH DEFICIENT PATHOLOGY IN HUMANIZED c.1066-11G>A PHENYLKETONURIA MICE;2023-11-05

4. Chaperone therapy for lysosomal and non-lysosomal protein misfolding diseases;Brain and Development;2023-05

5. Role of misfolding in rare enzymatic deficits and use of pharmacological chaperones as therapeutic approach;Frontiers in Bioscience-Landmark;2021-12-30